ENLV Enlivex Therapeutics, Ltd. Total Asset Value of Company
Enlivex Therapeutics (ENLV) is developing a non-cyclical emergency medicine vertical where the demand for sepsis treatment remains independent of seasonal or economic fluctuations. The market share price trend on the GURU.Markets platform shows that total assets amount to 1177.37. The company is creating a unique macrophage modification system that enables the body to independently suppress inflammation in severe pathologies and tumors, which is set to become a new standard in intensive care medicine.
Analytical breakdowns and data insights for company enlivex.com (ENLV)
- share price and consensus valuation forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Enlivex Therapeutics|ENLV - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Enlivex Therapeutics Ltd.|ENLV - Company Aggregate Debts|Debts to Book Capitalization Enlivex Therapeutics|ENLV - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Enlivex Therapeutics|Interim Coverage Ratio enlivex.com
- net income and valuation multiples indicators:
Fundamental valuation:Enlivex Therapeutics
Total assets represent the aggregate value of all corporate resources, calculated reversely via return on assets (ROA) to assess the fundamental stability of the business. Analyzing this total asset calculation allows an investor to compare the asset base of Enlivex Therapeutics (ENLV) with the potential for pricing power that the company gains through the creation of a unique cell reprogramming technology for sepsis therapy.
Key competitors
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|Company Assets Rigel Corp|AnaptysBio, Inc. (ANAB) - Aggregate Company Assets|Total Business Assets ATXS|Aggregate Company Assets enGene|Aggregate Company Assets RAPT|Company Total Assets JBIO|Company Total Asset Base Aclaris Therapeutics, Inc|Kyverna Therapeutics - Cumulative Company Assets|tizianalifesciences.com - Aggregate Company Assets|Cabaletta Bio - Company Total Assets|Company Assets Ventyx Biosciences Inc.|THTX (Theratechnologies Inc) - Cumulative Company Assets|Total Business Assets AVTX|Cumulative Company Assets ELDN|AGEN: Aggregate Asset Value|Cumulative Company Assets CLYM (Climb Bio)|Aggregate Business Assets ZURA|Company Total Assets ATYR (aTyr)|Aggregate Asset Value ADAG|Ikena Oncology, Inc. - Company Total Assets|Company Assets Shattuck Labs, Inc.|equilliumbio.com (EQ) - Aggregate Company Assets|Connect Biopharma Holdings Limited - Aggregate Asset Value|IMUX (Immunic Therapeutics) - Company Total Assets|Company Total Assets Atara Biotherapeutics Inc|Aggregate Company Assets InflaRx N.V. (IFRX)|XFOR: Total Asset Value of Company|Company Total Assets ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Company Assets|INMB: Cumulative Company Assets|BRNS - Company Total Assets|KZR (Kezar Life Sciences) - Cumulative Company Assets|SABS: Aggregate Business Assets|AKTX (Akari Therapeutics Plc) - Company Total Assets|Q32 Bio Corp (QTTB) - Company Total Asset Base|Company Total Assets GOVX|Cumulative Company Assets Edesa Biotech Corp EDSA|Aggregate Company Assets iBio, Inc. IBIO|Company Total Asset Base Carisma Therapeutics Inc (CARM)|XTL Biopharmaceuticals Ltd. - Company Total Assets|Company Assets Bolt Biotherapeutics|hcwbiologics.com (HCWB) - Aggregate Company Assets|Total Business Assets APVO|Aggregate Company Assets AIM ImmunoTech Inc.|Aggregate Company Assets ADTX|Cumulative Company Assets GRI (GRI Bio)|Aggregate Company Assets XRTX (XORTX Therapeutics Inc)|Aggregate Company Assets ReShape Lifesciences HIND|REVB (Revelation Biosciences Corp) - Total Asset Value of Company|Indaptus Therapeutics - Company Total Assets|Aggregate Asset Value SCNI (scinai.com)|CALI: Company Total Assets|Affimed N.V. (AFMD) - Company Total Assets|Aggregate Company Assets Allakos Inc|HOOK: Aggregate Asset Value|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Cumulative Company Assets iteostherapeutics.com ITOS|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD: Cumulative Company Assets